Altan Ahmed, MD

Cancer Focus:
Cholangiocarcinoma (Bile Duct Cancer), Kidney (Renal Cell) Cancer, Liver (Hepatocellular) Cancer, Neuroendocrine Tumor

Dr. Altan Ahmed is an Assistant Member in the Department of Diagnostic Imaging and Interventional Radiology. Dr. Ahmed earned his MD at the University of Alabama at Birmingham and his MS in Human Genetics from Tulane University School of Medicine. He completed a Diagnostic Radiology Residency at the University of Florida, where he also served as Chief Resident. He recently completed a Vascular and Interventional Radiology Fellowship at Mayo Clinic, Jacksonville, Florida. Dr. Ahmed’s clinical interests are in Interventional oncology including radioembolization, chemoembolization, microwave ablation and cryoablation. His primary research interest is the treatment of primary and metastatic liver malignancy and optimizing the conformality of locoregional therapies.

• Padia SA, Modi S, Wehrenberg-Klee E, Adamo RD, Ahmed A, Orloff M, Helmerhorst HJF, Chmielowski B, Ozkan OS, Burgmans MC, Grözinger MG, Lewandowski RJ, Krishnasamy VP. Treatment of Liver Metastases from Uveal Melanoma with Percutaneous Hepatic Perfusion. J Vasc Interv Radiol. 2026 Jan.37(1):107887. Pubmedid: 41138907.
• Sapell J, Al-Roubaie M, Ahmed A, Kocharyan H. Reevaluating the Utility of Liver Biopsies in Patients With Melanoma. Cureus. 2025 Oct.17(10):e94149. Pubmedid: 41209932. Pmcid: PMC12594535.
• Ghali H, Dugan MM, Aflatooni S, Boby A, DePalo DK, Laborde J, Choi J, Ahmed AF, Zager JS. ASO Visual Abstract: Hepatic and Overall Progression-Free Survival After Percutaneous Hepatic Perfusion as First- or Second-Line Therapy for Metastatic Uveal Melanoma. Ann Surg Oncol. 2025 Jan.32(1):501-502. Pubmedid: 39377841.
• Alayli A, Ngo H, Sikaria D, Ahmed A, Salloum E, Strosberg JR, Al-Toubah TE, Kis B, Haider M, El-Haddad G. Safety and Efficacy of Peptide Receptor Radionuclide Therapy (PRRT) Following Bland Embolization for Metastatic Neuroendocrine Tumors. Cancers (Basel). 2024 Jul.16(15). Pubmedid: 39123431. Pmcid: PMC11311572.
• Ghali H, Dugan MM, Aflatooni S, Boby A, DePalo DK, Laborde J, Choi J, Ahmed AF, Zager JS. Hepatic and Overall Progression-Free Survival After Percutaneous Hepatic Perfusion (PHP) as First-Line or Second-Line Therapy for Metastatic Uveal Melanoma. Ann Surg Oncol. 2024 Dec.31(13):9150-9158. Pubmedid: 39174837.
• Khoury J, Li B, Zhu J, Lin T, Hasan E, Lamba A, Gustainyte V, Kocharyan H, Yeisley C, Salloum E, Ahmed A, Greben C, Al-Roubaie M. Diagnosis and management of radiation cholecystitis as a complication of Y90 radioembolization for hepatocellular carcinoma. Radiol Case Rep. 2024 Aug.19(8):3363-3366. Pubmedid: 38832339. Pmcid: PMC11145197.
• Barakat E, Bibok A, Rishi A, Ahmed A, Frakes JM, Hoffe SE, Armaghani AJ, Soyano AE, Costa RLB, El-Haddad G, Choi J, Kis B. Transarterial Yttrium-90 Glass Microsphere Radioembolization of Chemotherapy-Refractory Breast Cancer Liver Metastases: Results of a Single Institution Retrospective Study. Adv Radiat Oncol. 2021 Oct.7(1):100838. Pubmedid: 35071835. Pmcid: PMC8767250.
• Bibok A, Mhaskar R, Jain R, Zhang J, Frakes J, Hoffe S, El-Haddad G, Parikh N, Ahmed A, Fishman MN, Choi J, Kis B. Role of Radioembolization in the Management of Liver-Dominant Metastatic Renal Cell Carcinoma: A Single-Center, Retrospective Study. Cardiovasc Intervent Radiol. 2021 Nov.44(11):1755-1762. Pubmedid: 34312688.
• Ahmed A, Stauffer JA, LeGout JD, Burns J, Croome K, Paz-Fumagalli R, Frey G, Toskich B. The use of neoadjuvant lobar radioembolization prior to major hepatic resection for malignancy results in a low rate of post hepatectomy liver failure. J Gastrointest Oncol. 2021 Apr.12(2):751-761. Pubmedid: 34012663. Pmcid: PMC8107583.
• Ahmed AF, Samreen N, Grajo JR, Zendejas I, Sistrom CL, Collinsworth A, Esnakula A, Shah JL, Cabrera R, Geller BS, Toskich BB. Angiosomal radiopathologic analysis of transarterial radioembolization for the treatment of hepatocellular carcinoma. Abdom Radiol (NY). 2018 Jul.43(7):1825-1836. Pubmedid: 29052747.
• Ahmed A, Verma N, Barreto I, Mohammed TL. Low-dose Lung Cancer Screening at an Academic Medical Center: Initial Experience and Dose Reduction Strategies. Acad Radiol. 2018 Aug.25(8):1025-1030. Pubmedid: 29395799.
• Reynolds RJ, Ahmed AF, Danila MI, Hughes LB, Gregersen PK, Raychaudhuri S, Plenge RM, Bridges SL. HLA-DRB1-associated rheumatoid arthritis risk at multiple levels in African Americans: hierarchical classification systems, amino acid positions, and residues. Arthritis Rheumatol. 2014 Dec.66(12):3274-3282. Pubmedid: 25524867. Pmcid: PMC4273668.
• Alebous HD, Cartee R, Vaccari D, Wright OA, Ahmed A, Hood RD, Johnson MD. Developmental control of inositol phosphate biosynthesis is altered in the brain of both curly and phenotypically normal straight tail mutant mice. Birth Defects Res A Clin Mol Teratol. 2009 Oct.85(10):822-827. Pubmedid: 19645052.